|
Orthologous residues
|
|
PXN (human): Y118‑p, PXN iso2 (human): Y118‑p, PXN iso3 (human): Y118‑p, PXN iso6 (human): Y125‑p, PXN (mouse): Y118‑p, PXN iso2 (mouse): Y118‑p, PXN (rat): Y118‑p, PXN (chicken): Y118‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody
|
|
Disease tissue studied:
neuroblastoma
|
|
Relevant cell lines - cell types - tissues:
Neuro-2A (neuron)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
siRNA
|
|
|
|
decrease
|
immunofluorescence, antisense myosin IIA
|
|
siRNA
|
|
|
|
no change compared to control
|
immunofluorescence, antisense myosin IIB
|
|
siRNA
|
|
|
|
decrease
|
immunofluorescence, antisense myosin IIA
|
|